BioSpace News Archive

Drug Development

Abeona Therapeutics Announces Presentations at the 27th European Society of Gene and Cell Therapy (ESGCT) Congress

27th European Society of Gene and Cell Therapy (ESGCT) Congress, to be held October 22-25, 2019 in Barcelona, Spain.

October 21, 2019
·
4 min read
BioMidwest

Bright Health Brings Its Innovative Model to Oklahoma in Collaboration with INTEGRIS Health in 2020

For the first time, Bright Health Plan will offer individual and family plans to residents of Oklahoma, Canadian and Cleveland Counties in 2020.

October 21, 2019
·
4 min read
Bio NC

Mycovia Pharmaceuticals to Present at 2019 BIO Investor Forum

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced that Chief Executive Officer Patrick Jordan will present at the 2019 BIO Investor Forum being held October 22-23 at the Westin St. Francis in San Francisco, Calif.

October 21, 2019
·
4 min read
Drug Development

Genentech’s Tecentriq in Combination With Avastin Increased Overall Survival and Progression-free Survival in People With Unresectable Hepatocellular Carcinoma

First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer

October 21, 2019
·
17 min read
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019

BNCT Cancer Therapy Facility at Edogawa Hospital Receives International Team of Eminent Physicians and Scientists

October 21, 2019
·
2 min read
Policy

Shape Memory Medical Receives CE Mark for the TrelliX® Embolic Coil System

Shape Memory Medical Inc. announced it has received CE mark for its TrelliX® Embolic Coil System.

October 21, 2019
·
3 min read
EOS imaging Announces First Cases Utilizing hipEOS 3.0 and Intellijoint HIP® Smart Navigation System via EOSlink™ at Hospital for Special Surgery (HSS)

Utilization of both technologies provides unique advantages in the optimization of Total Hip Arthroplasty (THA)

October 21, 2019
·
4 min read
Policy

Aerpio Pharmaceuticals Announces Review of Strategic Alternatives

Aerpio Pharmaceuticals, Inc. announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value from the Company’s clinical assets and cash resources, which amounted to $48.2 million as of June 30, 2019.

October 21, 2019
·
5 min read
Business

Quotient Limited to Report Second Quarter 2020 Financial Results and Host Conference Call

Quotient Limited, a commercial-stage diagnostics company, announced that financial results for its fiscal second quarter ended September 30, 2019, will be released before market open on Monday, November 4, 2019.

October 21, 2019
·
1 min read
Deals

Emergent BioSolutions to Host 2019 Analyst & Investor Day

Emergent BioSolutions Inc. announced that the company will host an analyst and investor day on November 21, 2019 in New York City.

October 21, 2019
·
1 min read